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Abstract
Abhay Sharma brings two arguments in favor of transgenerational epigenetic inheritance (TGEI) in mammals when
criticizing our work. He uses probability calculations and finds that the probability of obtaining the number of common
changes in the in utero-exposed prospermatogonia and the same cells in the next generation is significant in our
study. He also compares our results to other published datasets and concludes that the probability for the observed
overlap between independent studies is significant. We disagree with both arguments of Sharma and show here that
his meta-analysis and statistical calculations are not correct.
Sharma [1] directly criticized our paper [2] in the first
issue of Environmental Epigenetics in an attempt to defend
the prevailing dogma of transgenerational epigenetic
inheritance (TGEI) of environmentally induced changes in
mammals [3, 4]. The journal (Michael Skinner, Editor in
Chief) has not given us a chance to respond.
In the paper under dispute [2], we failed to find evi-
dence supporting TGEI at the level of transcription and
DNA methylation. We hypothesized that if an epigenetic
aberration was triggered in the male fetal germ cells by
environmental insult, it could be inherited by the sperm
and might prevail in the fetal germ cells of the next,
unexposed generation if not corrected by epigenome
reprogramming. Part of our work involved assessing
gene transcription in the fetal germ cells of the fetuses
exposed in utero to endocrine disruptors and in fetal
germ cells of the next generation (Table 4 in [2]). Any
change would be considered inherited if it was affecting
gene transcription similarly in the subsequent genera-
tions. Using rigorous statistics (1.5-fold change and FDR
P <0.05) to interpret our RNA microarray results, we
found an extremely low number of significant changes
in the exposed germ cells (seven and two probes total
for di(2-ethylhexyl)phthalate [DEHP] and vinclozolin
[VZ] exposures, respectively) but none of these prevailed
between generations. When we relaxed our statistical
stringency (1.5-fold change and unadjusted P <0.05), we
found one and eight probe overlaps between generations
for DEHP and VZ, respectively. Every one of these
changes occurred in the opposite direction in the
subsequent generation. These findings using generally
acceptable statistical rigor are consistent with the explan-
ation that germline epigenetic reprogramming corrects
the environment-induced mistakes in gene regulation.
In his first argument, Sharma selectively interpreted
our results by focusing only on the next part of our ana-
lysis, when we further reduced the statistical stringency
(1.05-fold change, P <0.05). He calculated the hypergeo-
metric probabilities for the common hits between genera-
tions and reported them to reach statistical significance.
At that extremely low level of statistical stringency we
counted 284 and 325 genes that exhibited changes in sub-
sequent generations for DEHP and VZ, respectively.
Among these, only 77/325 and 30/284 occurred in the
same direction (upregulated in two generations or
Correspondence: piroska.szabo@vai.org
Van Andel Research Institute, Center for Epigenetics, 333 Bostwick Ave,
Grand Rapids, MI 49503, USA
© 2016 Szabó. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Szabó Genome Biology  (2016) 17:105 
DOI 10.1186/s13059-016-0978-0
downregulated in two generations). We suggest that the
differences that are found in the opposite direction [2] may
indicate a slight overcompensation in the erasure process.
We disagree with Sharma’s opinion that a change that oc-
curs in the opposite direction in subsequent generations
constitutes an inherited epigenetic aberration. Further, a
decrease of a gene transcript in one generation and an in-
crease of the same transcript in the next generation cannot
account for the same phenotype in the subsequent genera-
tions. Therefore, molecular changes occurring in the op-
posite direction in subsequent generations should not be
combined in support of TGEI. Importantly, when we cal-
culated the hypergeometric distribution probabilities of the
number of changes that occurred in the same direction,
those numbers were not significant: P(x > = 77) = 1 for
DEHP and P(x > = 30) = 1 for VZ (Table 1).
Sharma argues [1]: “expression change in the opposite
direction across generations does not necessarily com-
promise the positive evidence of transgenerational ef-
fects because phenotypic variability across generations is
known in epigenetic inheritance. For example, transge-
nerational weakening and strengthening of phenotypes
have been reported in several studies in mammals.” He
also writes: “Moreover, gene expression changes in op-
posite direction across generations have also been re-
ported in studies pertaining to effects of environmental
agents in animals.” We would like to point out that the
papers cited by Sharma report results regarding: (1) a sin-
gle generation; (2) intergenerational changes that occur in
the same direction; (3) transgenerational phenotypic (not
molecular) changes that occur in the same direction
between three generations; (4) are non-mammalian exam-
ples; or (5) concern miRNA. Specifically, none of these
cited papers reports a TGEI phenotype that can be ex-
plained by a molecular change in the opposite direction
between the generation exposed as germ cells and the
next, unexposed, generation (or in the exposed germ cell
and germ cell of the next generation). Brieno-Enriquez [5]
reports that the embryonic phenotype, primordial germ
cell (PGC) number defect at 13.5 dpc and apoptosis at
13.5 dpc, occur in F1 and F2 PGCs but not in F3 PGCs.
The Let-7/LIN28/BLIMP1 pathway is misregulated in F1,
F2, and F3 PGCs. The direction of change is the same for
each component between F1 and F2 PGCs, exactly when
the phenotypic changes that can be anticipated from mis-
regulated BLIMP1 are actually observed in embryonic
germ cells. The direction of change is opposite for certain
components in the F3 PGCs, when the phenotype is no
longer observed.
For his second argument [1], Sharma compares our
data [2] to previously published rat and mouse datasets
using hypergeometric probability calculations. He writes
[1]: “In this analysis of mouse and rat gene expression
data from diverse studies, the entire set of human genes
listed in the Gene ontology was used for normalization,
to find overlap between previous gene sets and genes
identified by Iqbal and colleagues. The premise of this
analysis was that a higher-fold enrichment with greater
statistical significance in VZ-VZ comparison relative to
VZ-DEPH comparison would indicate TGEI. Import-
antly, a higher enrichment with greater significance is
observed for VZ-VZ overlap than VZ-DEPH overlap.”
To the contrary of his expectations, a lack of probability
of inter-study overlap is apparent in Figure 2 of Sharma
[1], where significance values should accompany the col-
umns according to the figure legend as they do in [6],
but only the columns pertaining to all 36 datasets com-
bined are labeled with statistical value. Using the same
gene lists Sharma used [1] (and one should use with cau-
tion, see below), we also counted the common hits and
calculated the hypergeometric probabilities of finding
common hits between our study [2] and previous studies
(Supplement 2 in [1], References to source data therein).
As displayed in Table 2, two comparisons are marginally
significant but the probability for finding an overlap per-
taining to all 36 datasets combined is not statistically
significant. We note that probabilities were calculated
without considering adjustments for multiple testing.
If we accounted for that, these probabilities would be
even larger.
There are several problems with Sharma’s interpre-
tations [1]: (1) he did not acknowledge the lack of
Table 1 Hypergeometric probability calculations for the common changes defined using extremely low stringency (1.05-fold, P <0.05)
detected in [2]
Number of genes (1.0 ST) DEHP G1R (Iqbal) DEHP G2R (Iqbal) DEHP G1R-G2R (Iqbal) Probability
21041 3639 1482 77 (same direction) 1
21041 3639 1482 248 (opposite direction) 0.73
21041 3639 1482 325 (both directions) 1.16E-06
Number of genes (1.0 ST) VZ G1R (Iqbal) VZ G2R (Iqbal) VZ G1R-G2R (Iqbal) Probability
21041 4295 1044 30 (same direction) 1
21041 4295 1044 254 (opposite direction) 8.94E-04
21041 4295 1044 284 (both directions) 4.04E-08
https://www.geneprof.org/GeneProf/tools/hypergeometric.jsp
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common hits at the rigorous statistical cutoff value but
only focused on the findings using extremely low statis-
tical stringency; (2) he made the assumption that the
changes occurring in the opposite direction between
studies could be considered common changes; (3) he
calculated the probability of obtaining the exact number
Table 2 Hypergeometric probability calculations for common VZ-induced changes between our study [2] and previous work considered
by Sharma [1]
Previous dataset Number of differentially
expressed genes in dataset
Common with VZ
G1R-G2R (Iqbal)
Probability Common with DEHP
G1R-G2R (Iqbal)
Probability
P = 21041 P = 21041
p(VZ) = 284 p(DEPH) = 325
F1 embryo male testis 83 0 1 0 1
F1 embryo E13 male testis 309 5 0.40 3 0.86
F1 embryo E14 male testis 162 2 0.65 2 0.72
F1 embryo E16 male testis 135 3 0.27 1 0.88
F2 embryo male testis 83 0 1 0 1
F3 embryo male testis 83 0 1 0 1
F3 adult male sertoli cells 383 10 0.04 9 0.14
F3 adult female granulosa cells 419 7 0.34 7 0.47
F3 adult female heart 113 0 1 2 0.52
F3 adult female kidney 451 9 0.16 9 0.26
F3 adult female liver 221 0 1 1 0.97
F3 adult female uterus 230 5 0.20 5 0.28
F3 adult male heart 113 1 0.79 2 0.52
F3 adult male kidney 93 2 0.36 1 0.77
F3 adult male liver 55 1 0.53 1 0.58
F3 adult male prostate 825 12 0.44 9 0.89
F3 adult male seminal vesicle 180 2 0.70 0 1
F3 adult female ovary 2555 29 0.86 31 0.94
F3 adult male testis 338 3 0.84 2 0.97
F3 adult male amygdala 224 2 0.81 1 0.97
F3 adult male hippocampus 71 1 0.62 0 1
F3 adult female amygdala 103 0 1 0 1
F3 adult female hippocampus 910 12 0.57 18 0.17
F3 adult male brain 642 3 0.99 5 0.97
F3 adult male basolateral amygdala 40 0 1 0 1
F3 adult male brain cortex 57 2 0.18 1 0.59
F3 adult male hippocampus CA1 74 0 1 0 1
F3 adult male hippocampus CA3 212 2 0.03 1 0.96
F3 adult female basolateral amygdala 48 1 0.48 0 1
F3 adult female brain cortex 79 0 1 0 1
F3 adult female hippocampus CA1 35 1 0.38 1 0.38
F3 adult female hippocampus CA3 25 0 1 0 1
F3 adult male ventral prostate 685 5 0.96 8 0.83
F3 adult male prostate epithelial cells 215 2 0.79 0 1
F3 embryo E13 male primordial germ cells 404 3 0.91 1 0.99
F3 embryo E16 male prospermatogonia 114 0 1 0 1
Cumulative (36 studies) 10769 125 0.96 121 0.99
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of successes in the sample (not the probability of obtain-
ing at least that many successes); (4) he did not apply
the same statistical cutoff values between studies; (5) he
used the number of known human genes as reference, but
this analysis should be limited to what can be detected by
the specific array; (6) he considered studies that did not
actually search for transgenerational changes in germ cells;
and (7) none of his study-to study comparisons reached
significant probability values in his Figure 2, yet he
concluded finding more significant overlap for VZ-VZ
than VZ-DEHP comparisons.
Based on the results of our study [2] and our reassess-
ment of Sharma’s calculations we cannot provide evidence
in support of TGEI in mammals.
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